Craig Johnson
Director/Board Member at TETRAPHASE PHARMACEUTICALS, INC.
Net worth: 167 841 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Kevin Tang | M | 57 |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 30 years |
| Michael Hearne | M | 61 | 9 years | |
| Aaron Davis | M | 45 | 8 years | |
| Craig Collard | M | 58 | 1 years | |
| Adam Morgan | M | 45 | 1 years | |
| Sandra Ramos-Alves | F | - | - | |
| Kimberly McCutcheon Jablonski | F | - | - | |
| Ryan Cole | M | - | 10 years | |
| Sharmila Dissanaike | M | 49 | 3 years | |
| Thomas B. Ottoboni | M | 65 | 12 years | |
| Susan Rodriguez | F | 60 | 3 years | |
| Christian Waage | M | 57 | 8 years | |
| Paul Reider | M | 55 | - | |
| Tony Hodges | M | - | 3 years | |
| Paula Rusu | F | - | 4 years | |
| Sophia Park | F | - | - | |
| Joseph Solomkin | M | - | - | |
| William Forbes | M | 62 | 1 years | |
| Pavel Raifeld | M | 40 | 2 years | |
| Chris Storgard | M | 58 | 6 years | |
| Sean T. Ristine | M | 54 | 10 years | |
| Marianne Zhen | F | 55 | 2 years | |
| Konstantina Katcheves | F | - | - | |
| Ira Duarte | F | 55 | 1 years | |
| Steven Pfeiffer | M | 48 | 8 years | |
| Luke Seikkula | M | 60 | 5 years | |
| John C. Arthur | M | 58 | 7 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Larry G. Edwards | M | 52 | 8 years | |
| Henry Fuchs | M | 66 |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 27 years |
| Kim Tsuchimoto | F | 61 | - | |
| Robert H. Rosen | M | 68 | 10 years | |
| John W. Poyhonen | M | 64 |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 15 years |
| David Szekeres | M | 50 | 7 years | |
| Stephen Davis | M | 63 |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 10 years |
| George Tidmarsh | M | 64 | 7 years | |
| Barry Quart | M | 67 | 11 years | |
| Lisa Peraza | F | 47 |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 16 years |
| Charles Baum | M | 65 | 12 years | |
| Laura Douglass | F | 59 | 9 years | |
| Christopher Starr | M | 71 | 7 years | |
| Robert Davis | M | 73 |
MitoKor, Inc.
 MitoKor, Inc. BiotechnologyHealth Technology MitoKor, Inc. provided discovery and diagnostic development of mitochondrial medicine. It was a biotechnology company focused on the research and development of drugs for the treatment of major diseases and conditions associated with mitochondrial dysfunction. The company was headquartered in San Diego, CA | 6 years |
| Mark Gergen | M | 61 | 3 years | |
| Perry Johnston | M | - | - | |
| Erich Sager | M | 66 | 6 years | |
| Richard Williams | M | 80 | 9 years | |
| Martin Godbout | M | - | 12 years | |
| Kimberly Manhard | F | 64 | 9 years | |
| Todd C. Zankel | M | 60 |
Raptor Pharmaceuticals Corp.
 Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to research and development a novel drug and drug-targeting platform intended to initially treat a variety of brain disorders, neurodegenerative diseases, cancer and metabolic diseases through the proprietary use of a natural human protein known as the receptor-associated protein (RAP). The Group is in development stage. The Group acquired Convivia, Inc in 2007. | 3 years |
| Neil M. Kurtz | M | 73 |
TorreyPines Therapeutics, Inc.
 TorreyPines Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TorreyPines Therapeutics, Inc. manufactures and distributes biopharmaceutical products. The company develops small molecule drugs to treat diseases and disorders of the central nervous system, chronic pain, neuropathic pain, cognitive disorders and alzheimer's disease. It was formerly known as Axonyx, Inc. The company is headquartered in La Jolla, CA. | 5 years |
| Evelyn A. Graham | F | 75 |
TPTX, Inc.
TorreyPines Therapeutics, Inc.
TorreyPines Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TorreyPines Therapeutics, Inc. manufactures and distributes biopharmaceutical products. The company develops small molecule drugs to treat diseases and disorders of the central nervous system, chronic pain, neuropathic pain, cognitive disorders and alzheimer's disease. It was formerly known as Axonyx, Inc. The company is headquartered in La Jolla, CA. | 3 years |
| Llew Keltner | M | 74 | 7 years | |
| Dennis Mulroy | M | 69 | 5 years | |
| Vickie Reed | F | 62 | 9 years | |
| Rodney Lappe | M | 69 | 7 years | |
| Neil Reisman | M | 62 | 1 years | |
| Jeffrey Jensen | M | - | - | |
| Maria D. Stahl | F | 53 | 5 years | |
| Stewart M. Kroll | M | 65 | 5 years | |
| John Lemkey | M | 43 | 7 years | |
| Felix Baker | M | 55 |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 2 years |
| John Moriarty | M | 56 | - | |
| Karen A. Klause | F | - | - | |
| David Meek | M | 59 | 2 years | |
| Inge Bear | F | - | - | |
| Jeffrey Chodakewitz | M | 68 | 6 years | |
| Jennifer Carver | F | 70 | 5 years | |
| Daniel Faga | M | 44 | 1 years | |
| Temre Johnson | M | - | 5 years | |
| Shubh Goel | M | 51 | - | |
| Maya Martinez-Davis | F | 54 | 6 years | |
| Sandra Vedrick | F | - | 6 years | |
| Tina Nova | M | 70 | 3 years | |
| John W. Beck | M | 64 |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 5 years |
| Marcy Graham | F | 57 | - | |
| Bruce Carter | M | 80 | 8 years | |
| Wendy Dixon | M | 68 |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 1 years |
| Robert B. Rothermel | M | 80 | 5 years | |
| William C. Denby | M | 69 | 5 years | |
| Nancy Wysenski | F | 66 | 6 years | |
| John Freund | M | 70 | 8 years | |
| Carol Gallagher | M | 59 | 1 years | |
| Patrick van Beneden | M | 62 |
TPTX, Inc.
TorreyPines Therapeutics, Inc.
TorreyPines Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TorreyPines Therapeutics, Inc. manufactures and distributes biopharmaceutical products. The company develops small molecule drugs to treat diseases and disorders of the central nervous system, chronic pain, neuropathic pain, cognitive disorders and alzheimer's disease. It was formerly known as Axonyx, Inc. The company is headquartered in La Jolla, CA. | 6 years |
| Faheem Hasnain | M | 65 | 5 years | |
| Leonard Patrick Gage | M | 81 | 9 years | |
| Raymond Anderson | M | 82 | 7 years | |
| Walter Moos | M | 69 |
MitoKor, Inc.
MitoKor, Inc. BiotechnologyHealth Technology MitoKor, Inc. provided discovery and diagnostic development of mitochondrial medicine. It was a biotechnology company focused on the research and development of drugs for the treatment of major diseases and conditions associated with mitochondrial dysfunction. The company was headquartered in San Diego, CA | 7 years |
| Brian Drazba | M | 63 | 4 years | |
| Shalini Sharp | F | 49 | 3 years | |
| Jack S. Remington | M | 93 |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 15 years |
| Peter Davis | M | 79 |
TPTX, Inc.
TorreyPines Therapeutics, Inc.
TorreyPines Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TorreyPines Therapeutics, Inc. manufactures and distributes biopharmaceutical products. The company develops small molecule drugs to treat diseases and disorders of the central nervous system, chronic pain, neuropathic pain, cognitive disorders and alzheimer's disease. It was formerly known as Axonyx, Inc. The company is headquartered in La Jolla, CA. | 4 years |
| Michael A. Adam | M | 66 | 5 years | |
| William Ringo | M | 78 | 2 years | |
| Mark Flather | M | - | 8 years | |
| Michael Grey | M | 71 | 7 years | |
| Garen Bohlin | M | 76 | 10 years | |
| Rick Franklin | M | 78 | 7 years | |
| Julie Cherrington | M | 66 | 5 years | |
| Kenneth M. Cohen | M | 68 | 3 years | |
| Kevin Kotler | M | 53 | - | |
| Aaron Ondrey | M | 48 | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Craig Johnson
- Personal Network